Background: The drug Gleevec (imatinib) is now widely used in treating CML (chronic myeloid leukemia). It is also approved worldwide for treating gastrointestinal stromal tumors (GIST). But in the case of GIST, it is not known if a dose of Gleevec that is higher than recommended is better or worse.
TUESDAY, Oct. 26 (HealthDayNews) -- A new kind of treatment against metastatic cancer cells, which carry cancer from one location to other parts of the body, has been identified by scientists at the Scripps Research Institute.
This treatment uses a class of drugs called Src kinase inhibitors to prevent metastatic cancer cells from leaving the bloodstream and invading other organs.
